Peter Chin-Hong MD @PCH_SF · 09 Jun 2023
Hoping new generation long-acting #COVID19 #monoclonalantibodies will be approved in time for potential winter surge #AZD3152 shows great promise in early studies. Ongoing trial (Supernova) in immunocompromised #ProjectNextGen will support new drugs https://t.co/CThfdYNzWW https://t.co/nvwePLoTFQ
5 972Views
18Likes
4Reposts
1Replies
0Quotes
3Bookmarks
Is that a lot?
2.17×vs 10K–100K median2 751 views is typical
50.24%Reachviews ÷ followers
0.39%Engagement rateof viewers reacted